Zacharon

Pfizer (NYSE: PFE) is expected to formally announce Thursday a $210 million partnership with Zacharon Pharmaceuticals. The collaboration is centered around Zacharon's work in developing treatments for genetic diseases known as “lysosomal storage disorders”. This partnership marks the first such...